| EPC0395 | Parrying the pitfalls of PrEP: preventing premature PrEP discontinuation and STIs among men who have sex with men | E-poster | HIV prevention research |
| EPC0394 | Pharmacokinetics and safety of long-acting islatravir and its novel prodrug islatravir alafenamide implants for HIV prevention | E-poster | HIV prevention research |
| EPC0393 | Peer-based model for reaching underserved MSM in Georgia | E-poster | HIV prevention research |
| EPC0392 | Indications, adherence and outcomes of HIV Post-Exposure Prophylaxis (PEP) among users in military health facilities in Uganda | E-poster | HIV prevention research |
| EPC0391 | Increasing PrEP continuation amongst key populations in 10 Priority Geographical Area (PGAs) in Namibia | E-poster | HIV prevention research |
| EPC0390 | Improvements in uptake of voluntary medical male circumcision in Malawi | E-poster | HIV prevention research |
| EPC0389 | Factors associated with retention of adolescents, girls, and young women in an HIV prevention program in South Africa | E-poster | HIV prevention research |
| EPC0388 | Bridging the gap: the impact of an empowerment based intervention on the knowledge of biomedical HIV prevention tools among sub-Saharan African precarious immigrants in France. Results from the Makasi project | E-poster | HIV prevention research |
| EPC0387 | Temporal change of PrEP use and adherence in MSM: pill fatigue or COVID-19 effect? | E-poster | HIV prevention research |
| EPC0386 | Developing and validating a screening tool for female genital schistosomiasis in urban Zambia | E-poster | HIV prevention research |